Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease Authors: Mario NietoMina KonigsbergAlejandro Silva-Palacios Reference: Biogerontology 2024 25 71–82 DOI: 10.1007/s10522-023-10068-5 See Abstract Key Words: Review articlecardiovascular diseasesenolyticsquercetindasatinibmechanism of action Back to index